CN101978074A - Non-competitive internal controls for use in nucleic acid tests - Google Patents China 用于核酸测试的非竞争性内部对照物  For nucleic acid testing noncompetitive internal control 技术领域  FIELD [0001] 本申请一般地涉及用于进行诊断分析的工具，更具体地涉及用于核酸测试（NAT) 的不与目标核酸序列竞争的内部对照序列。  [0001] The present application relates to a tool for performing diagnostic analysis in general, and more particularly, to a nucleic acid test for internal (NAT) is not a nucleic acid sequence with control sequences competing goals. [0002] 发明背景  [0002] Background of the Invention [0003] 为了确保核酸测试（NAT)正确地进行，分析需要存在内部对照物。  [0003] In order to ensure a nucleic acid test (NAT) correctly, analysis requires the presence of internal controls. 在诊断NAT中， 内部对照物的存在可以确保测试的完整性。  NAT diagnosis, the presence of internal controls to ensure the integrity of the test. 具体地，通过在NAT中包括内部对照物，内部对照物和目标核酸测试为阳性的样品是真阳性的。  In particular, by including an internal control, and internal control target nucleic acid in a test sample positive for NAT it is true positives. 相反，仅测试了内部对照物的样品是真阴性的，仅测试了目标核酸的样品是真阴性的，没有可检测的内部对照物或目标的样品是假阴性的。  Instead, only the internal control samples tested are true negatives, only the target nucleic acid test sample is truly negative samples no detectable internal control target or false negative. [0004] 需要存在内部对照物的最常用的诊断分析是聚合酶链式反应（PCR)分析，其在它的传统用途中是目标扩增分析，在它的修改的用途中是目标扩增和定量分析。  The most commonly used diagnostic assay [0004] require the presence of internal controls is the polymerase chain reaction (PCR) analysis, which is a target amplification assays in its conventional uses, it uses the modified target amplification and quantitative analysis. 存在几种类型的PCR分析：传统的PCR(DNA的扩增）；反-转录酶PCR(也称为“RT-PCR” ；利用RNA作为起始材料的DNA的扩增），实时PCR(DNA的同时定量和扩增）；和实时RT-PCR(利用RNA 作为起始材料的DNA的同时定量和扩增）。  There are several types of PCR analysis: conventional PCR (amplification of the DNA); trans - transcriptase PCR (also referred to as  " RT-PCR " ; DNA using RNA as the starting material for amplification), real-time PCR (DNA simultaneous quantification and amplification); and real-time RT-PCR (DNA using RNA as the starting material simultaneous quantification and amplification). [0005] 在扩增分析，例如PCR分析中，一般地，使用一种或两种内部对照物：竞争性内部对照物和非竞争性内部对照物。  [0005] In amplification assays, such as PCR analysis, generally, one or two internal control: competitive and non-competitive internal controls internal control. [0006] 使用竞争性内部对照物，目标和所述内部对照物在同样的条件下和在同一PCR试管中使用一组共同的引物来扩增。  [0006] The use of competitive internal controls, the target and the internal control under the same conditions and using a common set of PCR primers in the same tube to amplify. 使用竞争性内部对照物，内部对照物核酸侧翼是用于启动目标核酸的扩增的相同的引物序列。  Using a competitive internal controls, internal control nucleic acid is flanked by the same primer for starting amplification sequence of the target nucleic acid. 当正确地进行PCR分析时，IC核酸将在扩增分析之后检测到。  When properly performed PCR analysis, IC nucleic acid to be detected after amplification assays. 根据它的名字知道的是，竞争性内部对照物是基于目标DNA和内部对照物之间的竞争。  According to its name it is known competitive internal controls is based on the competition between target DNA and the internal control. 为了使竞争性内部对照物有效，样品试管中的内部对照物的数量对于检测极限是关键的。  For competitive internal control was effective, the number of sample tubes the internal control for the detection limit is critical. 使用竞争性内部对照物的缺点是基于它的结构，具体地，取决于核酸片段的摩尔比、长度、序列和二级结构，侧翼是相同的引物位点的两种不同的核酸片段的同时扩增有着一种或两种产物的抑制作用或增强作用的风险。  The disadvantage of using competitive internal controls is based on its structure, in particular, depending on the molar ratio of nucleic acid fragments, the length, sequence and secondary structure, flanked by two different spreading simultaneously the same primer sites nucleic acid fragment growth inhibition with one or two products or enhancement of risk. 竞争性内部对照物的另一个缺点是，它们不能用于多重分析，多重分析在单次分析中筛选多个目标。  Another disadvantage of competitive internal controls is that they can not be used for multiple analysis, multiplex analysis of multiple targets in a single screening analysis. [0007] 对于非竞争性内部对照物，对每一种利用不同的引物组扩增目标和内部对照物； 因而，非竞争性内部对照物需要一种PCR，在其中具有不同动力学的两个反应同时地进行。  [0007] For non-competitive internal controls, the target and internal control amplification for different primer sets each use; therefore, a need for a non-competitive internal controls the PCR, in which two different kinetics the reaction simultaneously. 由于两种反应的动力学是不同的，对于引物没有竞争。  Since the kinetics of the two reactions is different, there is no competition for the primers. 当前使用的非竞争性内部对照物引物组一般靶向目标基因以外的基因（例如，编码rRNA)，其以比目标基因更高的拷贝数存在于样品中。  Noncompetitive internal control primer set currently used are generally targeted gene other than the gene of interest (e.g., encoding rRNA), which is higher than the number of copies of the gene of interest present in a sample. 本领域中最常用的非竞争性内部对照物利用特异于16S和23S核糖体DNA的保守序列的引物。  The most commonly used in the art of non-competitive internal control using conserved sequences specific for 16S and 23S ribosomal DNA primers. 本领域中仍然需要可以被制备用于多重分析的其他非竞争性内部对照物。  There remains a need in the art may be used in the preparation of other non-competitive internal control of the multiplex analysis. 非竞争性内部对照物的优点是，不同于竞争性内部对照物，非竞争性内部对照物可以被保存用于多个反应，也可以用于多重反应中。  Advantage of non-competitive internal controls is that, unlike competitive internal controls, non-competitive internal controls can be stored for a plurality of the reaction, may also be used in multiplex reactions. 本领域中需要这样的非竞争性内部对照物。  We need in the art such noncompetitive internal control. [0008] 发明概述  [0008] Summary of the Invention [0009] 通过提供核酸序列，所述核酸序列可以在实验室中制备，并保存用于多个反应和用于多重NAT，本发明满足了本领域中对用于NAT的非竞争性内部对照物的需求。  [0009] The nucleic acid sequence may be prepared by providing a nucleic acid sequence in the laboratory, and saved for a plurality of multiple reactions and NAT, the present invention addresses the art for non-competitive internal control for the NAT It needs. 4[0010] 在本发明的一个方面，提供了用于核酸测试（NAT)的非竞争性内部对照物，包含从选自Methanobacterium thermoautrophicum(MET)和玉蜀黍（Zea mays)的生物体获得的核酸。  4 [0010] In one aspect of the present invention, there is provided a non-competitive internal control for nucleic acid testing (NAT), and comprising a nucleic acid obtained from a selected Methanobacterium thermoautrophicum (MET) and maize (Zea mays) organisms. [0011] 在本发明的一个实施方式中，所述非竞争性内部对照物包含DNA，并用于选自由甲型流感、乙型流感、副流感病毒1到4(PIV-1到PIV-4)、A型呼吸道合胞体病毒（RSV A) ,RSV B、人类偏月市病毒(human metapneumovirus, hMPV)、沙目艮衣原体(Chlamydiatrachomatis) (CT) ,Neisseria gonorrhea(GC[用于gonococci])和乙型肝炎病毒（HBV)构成的组的DNA NAT。  [0011] In one embodiment of the present invention, the non-competitive internal control comprises the DNA, selected from the group consisting of influenza and for influenza B, parainfluenza virus 1 to 4 (PIV-1 to PIV-4) , A-type respiratory syncytial virus (RSV A), RSV B, human metapneumovirus month City virus (human metapneumovirus, hMPV), sand mesh Gen trachomatis (Chlamydiatrachomatis) (CT), Neisseria gonorrhea (GC [for gonococci]) and B hepatitis B virus (HBV) DNA NAT group consisting of. [0012] 在本发明的另一个实施方式中，所述非竞争性内部对照物包含RNA，并用于选自由丙型肝炎病毒（HCV)、人类免疫缺陷病毒I (HIV-I)和严重急性呼吸综合征（SARS)构成的组的RNA NAT。  [0012] In another embodiment of the present invention, the non-competitive internal control comprises an RNA, and selected from the group consisting of a hepatitis C virus (of HCV), Human Immunodeficiency Virus I (HIV-I), and Severe Acute Respiratory syndrome (SARS) RNA NAT group consisting of. [0013] 在本发明的另一个方面，提供了制备用于核酸测试（NAT)的非竞争性内部对照物的方法，包括步骤：（a)从Methanobacteriumthermoautrophicum(MET)提取基因组DNA ； (b)利用具有至少两个限制性内切酶位点和至少一个目标特异性序列的正向和反向引物， 从步骤（a)的基因组DNA产生扩增子；（c)通过连接步骤（b)的扩增子和载体序列产生质粒，所述载体序列具有启动子序列和与所述扩增子的限制性内切酶位点相同的限制性内切酶位点；和(d)用与步骤（b)和（c)的限制性内切酶位点相应的限制性内切酶消化所述质粒来产生MET内部对照DNA。  [0013] In another aspect of the present invention, there is provided a method of preparing a noncompetitive internal control for nucleic acid testing (NAT), comprising the steps: (a) Genomic DNA was extracted from Methanobacteriumthermoautrophicum (MET); (b) the use of endonuclease sites and at least one target-specific sequence within the at least two forward and reverse restriction primer, generated from genomic DNA of step (a) amplicon; (c) by connecting step (b) expansion amplicon and generate the plasmid vector sequences, the carrier sequence has restriction enzyme endonuclease restriction sites within the same promoter sequence of the amplicon and restriction sites; and (d) a step (b ) restriction and (c) an enzyme site corresponding restriction endonuclease digestion of the plasmid to generate MET internal control DNA. [0014] 当需要RNA时，所述方法进一步包括步骤（e)：从步骤（d)的DNA制备MET内部对照RNA。  [0014] RNA when needed, the method further comprising the step (e): DNA was prepared from the internal control RNA MET step (d) is. [0015] 在本发明的进一步的方面，提供了制备用于核酸测试（NAT)的非竞争性内部对照物的方法，包括步骤：（a)从玉蜀黍（玉米（corn))提取基因组DNA ;(b)利用具有至少两个限制性内切酶位点和目标特异性序列的正向和反向引物，从步骤（a)的基因组DNA产生扩增子；（c)通过连接步骤（b)的扩增子和载体序列产生质粒，所述载体序列具有启动子序列和与所述扩增子的限制性内切酶位点相同的限制性内切酶位点；（d)用与步骤（b)和（C) 的限制性内切酶位点相应的限制性内切酶消化所述质粒来产生玉米内部对照DNA。  [0015] In a further aspect of the invention, there is provided a method of preparing a noncompetitive internal control for nucleic acid testing (NAT), comprising the steps: (a) from maize (corn (Corn)) the DNA Genomic; ( b) using endonuclease site and a target-specific sequence within the at least two forward and reverse restriction primers, amplicons generated from genomic DNA of step (a),; (c) by connecting step (b) is amplicon and generate the plasmid vector sequences, the vector sequence having a promoter sequence and cut with the restriction of the amplicon endonuclease site within the same restriction enzyme sites; (d) a step (b ) and restriction (C) an enzyme site corresponding restriction endonuclease digestion of the plasmid to generate an internal control corn DNA. [0016] 当需要RNA时，所述方法进一步包括步骤：(e)从步骤（d)的DNA制备玉米内部对照RNA。  [0016] RNA when needed, the method further comprising the step: (e) control RNA prepared from maize DNA internal step (d) is. [0017] 在本发明的一个实施方式中，步骤（b)和（d)的所述至少两个限制性内切酶位点(对于MET和玉米两者）相应于限制性内切酶XhoI和SpeI的序列。  [0017] In one embodiment of the present invention, the step (b) and (d) at least two tangential restriction enzyme site (for both MET and Corn) corresponding to the restriction endonuclease XhoI and SpeI sequence. [0018] 在本发明的另一个实施方式中，步骤（c)的启动子序列（对于MET和玉米两者） 是T7启动子序列。  [0018] In another embodiment of the present invention, the promoter sequence in step (c) (for both MET and Corn) is a T7 promoter sequence. [0019] 在本发明的进一步的实施方式中，MET或玉米内部对照DNA被用作选自以下构成的组的DNA NAT中的非竞争性内部对照物：甲型流感、乙型流感、副流感病毒1到4(PIV-1 到PIV-4)、A型呼吸道合胞体病毒（RSV A)、RSV B、人类偏肺病毒（hMPV)、沙眼衣原体（CT)、 Neisseria gonorrhea(GC)和乙型肝炎病毒（HBV)。  [0019] In a further embodiment of the present invention, the MET or Corn internal control DNA is used as selected from the group consisting of the DNA in the NAT noncompetitive internal control: influenza A, influenza B, parainfluenza virus 1 to 4 (PIV-1 to PIV-4), A-type respiratory syncytial virus (RSV A), RSV B, human metapneumovirus (hMPV), Chlamydia trachomatis (CT), Neisseria gonorrhea (GC) and B hepatitis virus (HBV). [0020] 在本发明又一个实施方式中，MET或玉米内部对照RNA被用作选自以下构成的组的RNA NAT中的非竞争性内部对照物：丙型肝炎病毒（HCV)、人类免疫缺陷病毒I (HIV-I)和严重急性呼吸综合征（SARS)。  [0020] In still another embodiment of the present invention described above, MET or Corn internal control RNA is used as the NAT RNA selected from the group consisting of a non-competitive internal control of: hepatitis C virus (HCV), Human Immunodeficiency virus I (HIV-I) and severe acute respiratory syndrome (SARS). 5[0021] 本发明的其他方面、优点和特征将在以下的说明书中部分地阐述，部分地，在本领域技术人员参阅下文时将变得显而易见，或可以通过本发明的实践来学习到。  5 [0021] Other aspects, advantages and features of the invention will be set forth in part in the description which follows and, in part, upon skilled in the art will become apparent hereinafter, refer to, or may be learned by practice of the invention. [0022] 附图的简要描述  [0022] Brief description of [0023] 附图1是制备本发明的内部对照序列的方法的示意图。  [0023] Figure 1 is a schematic view showing a method of the present invention, the internal control sequence. [0024] 附图2是单个反应孔中沙眼衣原体（CT)(左侧曲线）和MET IC(右侧曲线）的扩增曲线的图形。  [0024] Figure 2 is a single well Chlamydia trachomatis (CT) and graphics MET IC (right curve) of the amplification plot (left curve). [0025] 附图3是单个反应孔中Neisseria gonorrhea(GC)(左侧曲线)和MET IC(右侧曲线）的扩增曲线的图形。  [0025] Figure 3 is a graphical representation of a single reaction well Neisseria gonorrhea (GC) (left curve) and MET IC (right curve) of the amplification curve. [0026] 附图4是单个反应孔中丙型肝炎病毒（HCV)(左侧曲线）和MET IC(右侧曲线） 的扩增曲线的图形。  [0026] Figure 4 is a single well of HCV (of HCV) (left graph) and graphics MET IC (right curve) of the amplification curve. [0027] 发明的详细描述  [0027] Detailed Description of the Invention [0028] 以下阐述的是当前被认为是所请求的发明的优选的实施方式和最好实施例的描述。  [0028] Set forth below are presently considered to be preferred embodiments of the claimed invention and the best description of embodiments. 在功能、目的或结构方面的任何替代或修饰意图由本申请的权利要求涵盖。  Any alternatives or modifications are intended to function, structure or purpose of the present application is encompassed by the claims. [0029]定义：  [0029] Definition: [0030] 在描述和要求本发明的权利时，以下术语、以下定义仅被用于描述特定实施方式的目的，而不意图是限制性的。  [0030] In describing and claiming the present invention, the following terminology, the following definitions are used only for the purpose of describing particular embodiments, and is not intended to be limiting. 如在本说明书和附随的权利要求中使用的，单数形式“一(a)”、“一（an)”和“该（the) ”包括复数的指代物，除非上下文明显地相反指示。  As used in this specification and the appended claims, the singular forms  " a (A) " ,  " a (AN) "  and  " the (The) "  include plural referents unless the context clearly dictates otherwise. [0031 ] 术语“非竞争性内部对照物”是指内部对照核酸序列，其包括在目标核酸序列中不存在的引物位点。  [0031] The term  " non-competitive internal control "  refers to the internal control nucleic acid sequence comprising a primer sites are present in the target nucleic acid sequence. [0032] 术语“竞争性内部对照物”是指内部对照核酸序列，其包括在目标核酸序列中也存在的引物位点。  [0032] The term  " competitive internal controls "  refers to the internal control nucleic acid sequence, which comprises a primer sites in the target nucleic acid sequence, is also present. [0033] 术语“ FW”和“ FP ”表示正向引物，术语“ RV ”和“ RP ”表示反向引物。  [0033] The term  " FW "  and  " FP "  denotes the forward primer, the term  " RV "  and  " RP "  indicates reverse primer. 术语“ P ”单独使用时是指探针。  The term  " P "  used alone refers to the probe. [0034] 术语“用于内部对照物（IC)克隆的构建的PCR引物”是指寡核苷酸，其被设计以通过重叠PCR反应将独特的序列和限制性位点引入新构建的IC质粒DNA中。  [0034] The term  " used in the construction internal control (IC) cloned PCR primer "  refers to an oligonucleotide which is designed to PCR reaction by the overlapping sequences and unique restriction sites into the newly constructed plasmid IC DNA. [0035] 术语“扩增引物”(在此也称为“引物”）是指寡核苷酸，其与DNA或RNA分子互补， 并提供了底物的3-0H末端，任何DNA聚合酶可以按照5到3的方向将增长中的DNA链的核苷酸添加到所述末端上。  [0035] The term  " amplification primer "  (also referred to as  " primer " ) refers to an oligonucleotide, which is complementary to a DNA or RNA molecule, and provided 3-0H end of the substrate, any DNA polymerase may be 5-3 in the direction of the nucleotides in the growing strand of DNA is added to the end. [0036] 术语“检测探针”(在此也称为“探针”）是指在合适的条件下能够选择性地与扩增的目标核酸杂交的寡核苷酸。  [0036] The term  " detection probe "  (also referred to as  " probe " ) refers to an oligonucleotide capable of selectively hybridizing to the amplified target nucleic acid under suitable conditions. 检测探针可以由具有5-报告物染料（R)和3-淬灭剂染料（Q) 的核苷酸组成。  And detection probe can be a quencher dye 3- nucleotides (Q) consists of a 5- reporter dye (R). 荧光报告物染料和荧光团，或为红位移荧光的或非荧光的淬灭剂可以共价连接到寡核苷酸的5-末端或3-末端。  Non-fluorescent quencher dye and a reporter fluorescent fluorophores or fluorescent red displacement terminal may be connected to the 5- or 3-end of the oligonucleotide covalently. 检测探针在扩增和检测过程期间作为TAQMAN® (Applied Biosystems,Foster City,CA)探针或其他检测探针，例如信标、非核酸酶实时扩增探针。  Detection probe during amplification and detection process as TAQMAN® (Applied Biosystems, Foster City, CA) probe or other detection probes, such as real time amplification probe beacon, non nuclease. [0037] 术语“诊断目标（未知的），，是指已经设计了PCR分析来特异性地检测的核酸序列。这些分析的实例包括一些目标，例如，乙型肝炎病毒（HBV)、丙型肝炎病毒（HCV)和人类免疫缺陷病毒（HIV)。  [0037] The term  " diagnosis target (unknown) ,, refers to nucleic acid sequences have been designed to specifically PCR analysis detected. Examples of such analyzes include certain objectives, e.g., hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). [0038] 术语“诊断目标（已知的）”是指独特的DNA或RNA目标，其以已知的浓度掺入到用于分离和扩增特定诊断目标的提取步骤或扩增混合物中，所述特定诊断目标在样品中的存在或数量是未知的。  [0038] The term  " diagnosis target (known) "  refers to a unique DNA or RNA target, which is incorporated into a known concentration of an extraction step for separating and amplifying the target specific diagnostic or amplification mixture, the diagnosis of the presence or amount of said specific target in a sample is unknown. 此外，识别RNA或DNA的独特片段的独特的引物和探针被添加到扩增混合物中。  In addition, unique primers and probes unique fragments of DNA or RNA identification is added to the amplification mixture. 这些内部对照物可以用于监视实时kPCR分析中目标提取、扩增和检测的效力。  These internal controls can be used to monitor real-time kPCR assay target extraction, amplification and detection efficacy. [0039] 如在此使用的，术语“目标扩增”是指酶介导的过程，其能够产生核酸目标的数十亿的拷贝。  [0039] As used herein, the term  " target amplification "  refers to an enzyme-mediated process, copies of the target nucleic acid which is capable of producing billions. 本领域已知的酶介导的目标扩增过程的实例包括PCR、基于核酸序列的扩增(“NASBA”)、转录介导的扩增（“TMA”)、链置换扩增（“SDA”）和连接酶链式反应（“LCR”)。  Examples known in the art enzyme-mediated target amplification process include PCR, nucleic acid sequence based amplification (  " NASBA " ), transcription mediated amplification (  " TMA " ), strand displacement amplification (  " SDA "  ) and ligase chain reaction (  " LCR " ). 最广泛使用的目标扩增过程是PCR，由Mullins等人在美国专利No. 4，683，195中和Mullis 在美国专利No. 4，683，202中首先描述用于DNA的扩增。  The most widely used target amplification procedure is PCR, the amplified DNA for Mullins et al in U.S. Pat. No. 4,683,195 and Mullis first described in U.S. Patent No. 4,683,202. PCR过程是本领域普通技术人员公知的。  PCR is a process known to those of ordinary skill in the art. 当PCR反应的起始材料是RNA时，互补DNA(“cDNA”）通过逆转录由RNA制成。  When the starting material is RNA PCR reaction, the complementary DNA (  " cDNA " ) is made from RNA via reverse transcription. 用于扩增RNA产物的PCR被称为逆转录酶PCR或“RT-PCR”。  PCR is used to amplify RNA products is referred to as reverse transcriptase PCR or  " RT-PCR " . [0040] 在PCR技术中，DNA的样品在溶液中与摩尔过量的、各自10_30碱基对的两种寡核苷酸引物，所述引物各自制备为互补于DNA双链体的每条链的3 ' 末端；摩尔过量的未连接的核苷酸碱基（即，dNTPs)；和DNA聚合酶（优选的Taq聚合酶，其是对热稳定的），其催化从寡核苷酸引物和dNTP的DNA形成，混合。  [0040] In PCR technique, the DNA sample in solution with molar excess of each of two oligonucleotides 10_30 bp nucleotide primer, each prepared as a primer complementary to each strand of the duplex DNA 3  ' end; molar excess of unattached nucleotide bases (i.e., dNTPs); and DNA polymerase (preferably Taq polymerase, which is stable to heat), which catalyzes the oligonucleotide primers and dNTP forming a DNA hybrid. 两种引物中，一种是正向引物，其将以5 '  -3 '  方向结合变性的DNA被分析物的一条链的3 ' 末端，另一个是反向引物，其将以3 '  -5 ' 方向结合变性的DNA被分析物的另一条链的5  ' 末端。  Two primers, one is a forward primer that will bind denatured 5  ' -3 '  direction of the DNA analyte strand 3  ' end of the other is a reverse primer that will 3 ' -5 '  direction of the denatured DNA analyte bound 5  ' end of the other strand thereof. 溶液加热到94-96°C来将双链DNA变性为单链的DNA。  The solution was heated to 94-96 ° C to denature the double-stranded DNA to single stranded DNA. 当溶液冷却时，引物结合独立的链，DNA聚合酶通过将dNTP结合到引物上来催化被分析物的新的链。  When the solution cooled, a separate strand primer binding, dNTP binding by the DNA polymerase to be analyzed catalytic primer onto the new chains thereof. 当重复该过程时，从引物合成的延伸产物从它们的互补物上分离，每个延伸产物充当了从另一个引物合成的互补延伸产物的模板。  When the process is repeated, synthesized from the primer extension product separated from their complements, each extension product serves as a template complementary to the extension product synthesized from the other primer. 换句话说，从正向引物合成的延伸产物，在分离时，将充当从反向引物合成的互补的延伸产物的模板。  In other words, the forward primer extension product is synthesized, and when separated, will act as a template synthesized from the reverse primer extension product is complementary. 类似地，从反向引物合成的延伸产物，在分离时，将充当从正向引物合成的互补的延伸产物的模板。  Similarly, the reverse primer extension product synthesis, upon separation, would serve as a template synthesized from the forward primer extension product complementary. 这样，引物之间的DNA的区域随着过程的每次重复被选择性地复制。  Thus, the region of DNA between the primers is repeated with each selectively copying process. 由于在每个循环之后序列被扩增加倍，十亿个拷贝的理论上的扩增可以在重复该过程几个小时后获得；因而，极小数量的DNA可以利用PCR在相对短的时间内扩增。  Since the sequence to be amplified after each cycle is doubled, one billion copies of the amplification theoretically possible to obtain a few hours after the procedure is repeated; Thus, the minimum number of PCR amplification of DNA can be utilized in a relatively short period of time increase. [0041 ] 如在此使用的，术语“扩增子”是指扩增的核酸产物，例如，扩增的PCR产物。  [0041] As used herein, the term  " amplicon "  refers to a nucleic acid amplification product, e.g., amplified PCR product. [0042] 当PCR反应的起始材料是RNA时，互补DNA (“cDNA”）通过逆转录由RNA制成。  [0042] When the starting materials during the PCR reaction is RNA, complementary DNA (  " cDNA " ) is made from RNA via reverse transcription. 产生的cDNA然后利用如上所述的PCR方案扩增。  cDNA was then generated by PCR amplification scheme as described above. 逆转录酶作为在逆转录病毒中发现的酶是本领域普通技术人员已知的，其可以从mRNA序列作为模板合成互补的DNA单链。  Reverse transcriptase, an enzyme found in retroviruses are known to those of ordinary skill in the art, which can be used as template for the synthesis of complementary single-stranded DNA from the mRNA sequence. 所述酶被用于遗传工程中来从mRNA的纯化的制品产生特定的cDNA分子。  The enzymes are used in genetic engineering to produce specific cDNA molecules from purified preparations of mRNA. 用于扩增RNA产物的PCR 被称为逆转录酶PCR或“RT-PCR”。  PCR is used to amplify RNA products is referred to as reverse transcriptase PCR or  " RT-PCR " . [0043] 术语“实时PCR，，和“实时RT-PCR”本领域中也称为“动力PCR，，( “kPCR” )或“动力RT-PCR” ( “kRT-PCR”），是指用于DNA的同时扩增和定量的修改的PCR分析。  [0043] The term  " real-time PCR ,, and "  real-time RT-PCR  " in the art is also referred to as "  Dynamic PCR ,, (  " kPCR " ) or  " power RT-PCR "  (  " kRT-PCR " ), refers to the use analysis for the simultaneous amplification and quantification of DNA modified PCR. 对于实时PCR，通过由发荧光染料分子和淬灭剂部分与相同的或不同的寡核苷酸底物的偶联所产生的荧光信号，来检测PCR产物。  For real-time PCR, the fluorescence signal from the fluorescent dye molecule and a quencher moiety coupled with the same or different oligonucleotide substrates produced, for detection of PCR products. 在kPCR和kRT-PCR中通常使用的探针的实例包括以下探针：TAQMAN®探针（Applied Biosystems, Foster City, CA)、分子信标探针（PHRI，Neward, NJ )、SCORPION® 探针（DXS Ltd, Manchester, UK)和SYBR®Green 探针（Invitrogen，Carlsbad，CA)。  Examples of the probe and the kPCR kRT-PCR typically include the following probes: TAQMAN® probe (Applied Biosystems, Foster City, CA), molecular beacon probes (PHRI, Neward, NJ), SCORPION® probe (DXS Ltd, Manchester, UK) and SYBR®Green probe (Invitrogen, Carlsbad, CA). 简要地，TQMAN® 探针、分子信标和SCORPION® 探针各自具有附着到探针的5 ' 末端的荧光报告物染料（也称为“荧光剂”）和偶联到探针的3 ' 末端的淬灭剂部分。  Briefly, TQMAN® probe, molecular beacon probes and SCORPION® each having a probe attached to the 5  ' end fluorescent reporter dye (also referred to as  " phosphor " ) coupled to the probe and the 3 '  end the quencher moiety. 在未杂交的状态下，荧光剂和淬灭分子的接近阻止了来自探针的荧光信号的检出。  In the unhybridized state, the proximity fluorescer and quencher molecules prevents the detection of fluorescent signal from the probe. 相反，在PCR期间，当聚合酶复制其上结合了探针的模板时，聚合酶的5 ' -核酸酶活性裂解探针，因而每个复制循环提高荧光。  In contrast, during the PCR, when the polymerase to copy the template on which a probe binding, the 5 ' -nuclease activity of the polymerase cleaves the probe, so that each replication cycle increase in fluorescence. SYBR® Green探针结合双链DNA，并在激发时发射光线；因而随着PCR产物积累，荧光提高。  SYBR® Green probe the DNA duplex is bound, and upon excitation emit light; and thus as PCR product accumulated, the fluorescence is improved. [0044] 术语“互补的”和“基本上互补的”是指核苷酸或核酸之间的碱基配对，例如，在双链DNA分子的两条链之间，或在寡核苷酸引物和要测序或扩增的单链核酸上的引物结合位点之间。  [0044] The term  " complementary "  and  " substantially complementary "  refers to the base pairing between nucleotides or nucleic acids, e.g., between the two strands of the double stranded DNA molecule, or an oligonucleotide primer and primers on single stranded nucleic acid to be sequenced or amplified between the binding sites. 互补的核苷酸一般是，A和T(或A和U)，以及G和C。  Complementary nucleotide generally, A and T (or A and U), and G and C. 在本发明的上下文中，要理解的是，列出的具体序列长度是说明性的，不是限制性的，并且，覆盖相同的图谱位置、但具有稍稍更少或更多数量的碱基的序列被认为是所述序列的等同物，并且属于本发明的范围，条件是它们将与所列序列一样杂交到目标上的相同位置。  In the context of the present invention, it is to be understood that the specific length of the sequence listed are illustrative and not restrictive, and covering the same map positions but having slightly fewer or greater sequence number of bases or of It is considered equivalents of the sequence, and within the scope of the present invention, provided they will hybridize to the sequences set forth as in the same location on the target. 因为要理解的是，为了杂交， 核酸不需要完全互补，在此公开的探针和引物序列可以被一定程度上修饰而不损失作为具体引物和探针的实用性。  Because be understood that for hybridization, the nucleic acid need not be completely complementary to the probe and primer sequences herein disclosed may be modified to some extent without loss of utility as specific primers and probes. 一般地，具有80%或更高同源性的序列属于本发明的范围。  In general, it has a range of 80% or higher sequence homology to belong to the present invention. [0045] 如在此使用的，术语“克隆”被用于指“分子克隆”，其是产生核酸序列的多个拷贝(在此也称为 " 插入物 " ）的一种过程，例如，来自插入物的单个拷贝的独特基因或可选择的遗传标志物。  [0045] As used herein, the term  " cloning "  is used to refer to  " Molecular Cloning " , which is a process that a plurality of copies (also referred to as  " insert " ) generated nucleic acid sequences, e.g., from insert a single copy gene or a unique selectable genetic marker. 克隆过程一般在“克隆载体”（在此也称为 " 载体 " ）中发生，其是一种能够在适合的宿主细胞中复制的DNA分子，例如，质粒或病毒DNA染色体。  In general the cloning process,  " cloning vector "  (also referred to as  " carrier " ) occurs, which is capable of replication in a suitable host cell a DNA molecule, e.g., a plasmid or viral DNA chromosome. “质粒”是本领域已知的，从细菌物种获得的环状双链DNA分子。 " Plasmid "  are known in the art, the cyclic double-stranded DNA molecules obtained from a bacterial species. 克隆载体一般具有用于核酸序列的插入的一个或更多个适合的位点。  Cloning vector generally has a nucleic acid sequence for insertion of one or more suitable sites. 在成功的克隆中，克隆载体被导入宿主细胞中，克隆载体在宿主细胞中的复制产生转化的宿主细胞，其表达被插入到所述克隆载体中的所述核酸序列。  In a successful cloning, the cloning vector is introduced into host cells, cloning vector to replicate in the host cell transformed host cells that express the nucleic acid sequence is inserted into the cloning vector. 克隆载体在宿主细胞中的复制一般经由“启动子”来启动，其是位于基因的上游（朝向5 ' 区域）的DNA的调节区域，其结合RNA聚合酶和转录因子来启动RNA转录。  Cloning vector to replicate in a host cell typically via  " promoter "  start, which gene is located upstream (towards the 5  ' region) regulatory region of DNA that binds RNA polymerase and transcription factors to initiate RNA transcription. 利用这种操作和如附图1中所示的，克隆载体可以用作模板来通过常规转录反应产生RNA内部对照物，或通过限制性消化产生DNA内部对照物。  With this operation, and as shown in the drawings, the cloning vector may be used as a template to produce the reaction by conventional RNA internal control transcription, or DNA generated by restriction digestion internal controls. [0046] 如在背景小节中解释的，当非竞争性内部对照物用于扩增反应，例如PCR时，不同的引物集被用于内部对照物和用于目标。  [0046] As explained in the background section, when the non-competitive internal control for amplification reactions such as the PCR, the different primer sets are used for internal control and targets. 非竞争性内部对照物的使用因而需要一种PCR， 其中具有不同的动力学的两种反应同时进行，每个反应的动力学不受到对引物的竞争的影响。  Using the non-competitive internal control is thus a need for the PCR, which has two different reaction kinetics at the same time, each of the reaction kinetics are not influenced by the competitive primer. [0047] 非竞争性内部对照物相对竞争性内部对照物的一个优点是，由于非竞争性内部对照物是用它们自己的引物集来制备的，它们可以用于同一实验室中的许多不同的分析。  [0047] a competitive advantage relative to the internal controls are noncompetitive internal control, non-competitive internal control with their own set of primers prepared because they can be used in the same laboratory many different analysis. 非竞争性内部对照物的另一个优点是它们可以用于多重PCR分析。  Another advantage of non-competitive internal controls is that they can be used in multiplex PCR analysis. 相反，竞争性内部对照物不能用于多重PCR分析，在多重PCR分析中需要几个引物对。  In contrast, competitive internal controls can not be used for multiplex PCR analysis, multiplex PCR assay requires several primer pairs. 如技术人员已知的，多重PCR 对于分子诊断是非常有用的，因为产生相似症状的多种病原体可以在单个反应中同时地筛选。  As known to skilled artisans, multiplex PCR for the molecular diagnosis is very useful, because multiple pathogens produce similar symptoms can be screened simultaneously in a single reaction. [0048] 本发明的非竞争性内部对照物具有至少两个引物结合位点和至少一个探针结合位点。  [0048] The non-competitive internal controls of the present invention has at least two primer binding sites and at least one probe binding site. 作为非竞争性对照物，本发明的内部对照物具有独特的克隆序列，其不与目标核酸序列竞争。  As a non-competitive controls, internal controls of the present invention has a unique sequence clones, which does not compete with the target nucleic acid sequence. 所述内部对照物是从生物体Methanobacterium thermoautrophicum(MET)和玉蜀黍（玉米）的基因组独立地设计的。  The internal control is from an organism Methanobacterium thermoautrophicum (MET) and maize (corn) genome independently designed. 分离自所述生物体的核酸被构建到带有克隆载体的质粒中。  Nucleic acid isolated from the organism to be constructed with a plasmid cloning vector. [0049] 用于克隆核酸的操作是本领域技术人员已知的。  Operation [0049] for cloning nucleic acids are known to the skilled person. 附图1显示了克隆本发明的内部对照物核酸的示范性的操作；附图1中阐述的操作被用于产生实施例中描述的非竞争性内部对照物。  Figure 1 shows an exemplary operation of the internal control was cloned nucleic acid of the present invention; in one operation set forth in the accompanying drawings are used to generate non-competitive internal controls described embodiment. 如附图1中所示，分离的基因组DNA用XhoI和SpeI限制性内切酶消化，产生的DNA插入物利用PCR来扩增并纯化。  As shown in FIG. 1, the isolated genomic DNA was digested with restriction enzyme XhoI and SpeI restriction, DNA was generated by PCR insert was purified and amplified. 单独地，从TOPO®克隆载体（Invitrogen，Carlsbad， California)制备载体片段，其用XhoI和SpeI限制性内切酶消化来形成具有XhoI和SpeI 粘性末端的载体片段，其随后被纯化。  Separately, a vector fragment prepared from TOPO® cloning vector (Invitrogen, Carlsbad, California), digested with enzymes which cut XhoI and SpeI restriction fragments to form a carrier having XhoI and SpeI cohesive ends, which is then purified. DNA插入物和载体片段然后通过匹配XhoI和SpeI粘性末端来连接，形成包括了基因组DNA插入物、载体片段和T7启动子序列的质粒。  DNA insert and the vector fragment is then connected by matching XhoI and SpeI sticky ends, it is formed comprising a genomic DNA insert fragment and the vector plasmid T7 promoter sequence. T7启动子序列一般是20-mer T7 启动子序列5 ' -TAA TAC GAG TCA CTA TAG GG-3，(SEQ ID NO. 1) 或21-mer T7 启动子序列5，-TAA TAC GAG TCA CTA TAG GGA-3，(SEQ ID NO. 2)。  T7 promoter sequences are generally 20-mer T7 promoter sequence 5 ' -TAA TAC GAG TCA CTA TAG GG-3, (SEQ ID NO. 1) or 21-mer T7 promoter sequence 5, -TAA TAC GAG TCA CTA TAG GGA-3, (SEQ ID NO. 2). 本发明的内部对照DNA序列通过用XhoI或SpeI消化质粒来产生。  Internal control DNA sequence according to the present invention by digestion of the plasmid with XhoI or SpeI to generate. 内部对照RNA序列通过在本领域技术人员已知的条件下转录DNA来获得。  Internal control RNA obtained by transcription of the DNA sequence under the present conditions known to skilled in the art. [0050] 对附图1中所示操作的修饰，例如，用本领域已知的其他启动子替换T7启动子，例如T3和SP6启动子，或在MET或玉米插入物侧翼插入超过一个启动子，处于本领域技术人员的技术水平之内。  [0050] The modification operation shown in the drawings, for example, replacing the T7 promoter by other promoters known in the art, for example, T3 and SP6 promoter, is inserted in or flanking the insert MET more than one promoter or maize , within the level of skill in the art. 类似地，处于本领域技术人员的技术水平之内的是，用其他适合的限制性内切酶的结合位点替换XhoI和SpeI限制性结合位点，来修改在此阐述的方法。  Similarly, at the level of skill of the art are replaced by the endonuclease restriction Other suitable binding sites XhoI and SpeI restriction sites binding to modification method set forth herein. [0051] 本发明的DNA内部对照物在DNA核酸测试（DAT)中具有实用性，无限制地包括： 甲型流感、乙型流感、副流感病毒1到4(PIV-1到PIV-4)、A型呼吸道合胞体病毒（RSV A)、 RSV B、人类偏肺病毒（hMPV)、沙眼衣原体（CT)、Neisseria gonorrhea(GC)和乙型肝炎病毒（HBV)。  [0051] DNA internal control of the present invention have utility in DNA nucleic acid test (DAT) are, without limitation: influenza A, influenza B, parainfluenza virus 1 to 4 (PIV-1 to PIV-4) , A-type respiratory syncytial virus (RSV A), RSV B, human metapneumovirus (hMPV), Chlamydia trachomatis (CT), Neisseria gonorrhea (GC) and hepatitis B virus (HBV). [0052] 本发明的RNA内部对照物在RNA核酸测试（NAT)中具有实用性，无限制地包括：丙型肝炎病毒（HCV)、人类免疫缺陷病毒I(HIV-I)和严重急性呼吸综合征（SARS)。  [0052] RNA internal control of the present invention have utility in RNA nucleic acid testing (NAT) in, without limitation: hepatitis C virus (of HCV), Human Immunodeficiency Virus I (HIV-I), and Severe Acute Respiratory integrated syndrome (SARS). [0053] 实际上，要理解的是，本发明的内部对照物被包括在与被靶向的样品相同的反应混合物中。  [0053] In practice, to be understood that the internal controls of the present invention are included in the targeted sample in the same reaction mixture. 在本发明的一个实施方式中，在病毒裂解的步骤引入内部对照物，因而，可以用于在样品制备步骤监测RNA或DNA目标捕获或释放，和/或监测在实时PCR期间的目标扩增和检测。  In one embodiment of the present invention, the step of introducing viral lytic internal control, therefore, can be used to monitor the target DNA or RNA in a sample preparation step to capture or release and / or monitoring a target during real-time PCR amplification and detection. [0054] 内部对照物片段和引物和探针集：  [0054] fragments and internal control primer and probe sets: [0055] 序列表描述了⑴克隆期间的DNA插入物；（ii)基于限制性内切酶消化之后的纯化，产生的完整的双链DNA序列；和（iii)产自带有附着的载体序列的T7启动子的单链RNA 的序列。  [0055] The following table describes the DNA sequence of the insert during cloning ⑴; (ii) based on the complete sequence of the double-stranded DNA after restriction enzyme digestion yielded a; and (iii) yield comes with attached vector sequences single-stranded RNA sequence of the T7 promoter. [0056] MET核酸片段  [0056] MET nucleic acid fragment [0057] 表1显示了用于从M thermoautrophicum(MET)基因组提取核酸片段的正向（FP) 和反向（RP)弓丨物的序列，其被用于克隆本发明的MET内部对照物（MET IC)。  [0057] Table 1 shows the sequence for the extraction of nucleic acid fragments from M thermoautrophicum (MET) genomic Forward (FP) and reverse (RP) was Shu bow, which is used for cloning MET internal controls of the present invention ( MET IC). 引物被设计具有限制性内切酶结合位点（以粗体突出）和目标特异性结合位点（下划线的）。  Primers are designed with restriction enzymes binding sites (highlighted in bold) and target specific binding sites (underlined). 如其中所示，正向引物被设计具有XhoI限制性内切酶序列（C/TCGAG)，反向引物被设计具有SpeI限制性内切酶序列（A/CTAGT)。  As shown therein, the forward primers are designed with restriction endonuclease XhoI enzyme sequence (C / TCGAG), the reverse primers are designed with restriction endonuclease SpeI enzyme sequence (A / CTAGT). [0058]  [0058] 9  9 [0059] 如上所指出的，本发明的内部对照物包括至少两个引物结合位点和至少一个探针结合位点。  [0059] As indicated above, the internal controls of the present invention comprises at least two primer binding sites and at least one probe binding site. 表2到8阐述了各种正向和反向扩增引物序列和检测探针结合序列，其被用于产生MET IC扩增子，这也在表格中提供了。  Table 2-8 set forth various forward and reverse amplification primer sequences and detection probe binding sequences, which are used to produce amplicons MET IC, which is also provided in the table. 表2到8中阐述的扩增子可以用于制备用于以下疾病状态的核酸诊断测试的非竞争性对照物：甲型流感、乙型流感、副流感病毒1到4(PIV-1到PIV-4)、A型呼吸道合胞体病毒（RSV A)、RSV B、人类偏肺病毒（hMPV)、沙眼衣原体（CT)、Neisseria gonorrhea (GC)、乙型肝炎病毒（HBV)、丙型肝炎病毒（HCV)、人类免疫缺陷病毒I (HIV-I)和严重急性呼吸综合征（SARS)。  Tables 2 to 8 set forth amplicon be used to prepare nucleic acid diagnostic tests for the following disease states noncompetitive controls: influenza A, influenza B, parainfluenza virus 1 to 4 (PIV-1 to PIV -4), A-type respiratory syncytial virus (RSV A), RSV B, human metapneumovirus (hMPV), Chlamydia trachomatis (CT), Neisseria gonorrhea (GC), hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus I (HIV-I) and severe acute respiratory syndrome (SARS). [0060]  [0060] [0061]  [0061] [0065]  [0065] [0066]  [0066] [0067] 玉米核酸片段  [0067] The nucleic acid fragments of Maize [0068] 表9显示了用于从玉蜀黍（玉米）基因组提取核酸片段的正向（FP)和反向（RP) 引物的序列，其被用于克隆本发明的玉米内部对照物（玉米IC)。  [0068] Table 9 shows the sequence used to extract nucleic acid fragments from maize (corn) genome Forward (FP) and reverse (RP) primer, which are internal controls of the present invention for cloning corn (maize IC) . 引物被设计具有限制性内切酶结合位点（以粗体突出）和目标特异性结合位点（下划线的）。  Primers are designed with restriction enzymes binding sites (highlighted in bold) and target specific binding sites (underlined). 如其中所示，正向引物被设计具有Xhol限制性内切酶序列（C/TCGAG)，反向引物被设计具有Spel限制性内切酶序列(A/CTAGT)。  As shown therein, the forward primers are designed with restriction endonuclease Xhol enzyme sequence (C / TCGAG), the reverse primers are designed with restriction endonuclease Spel enzyme sequence (A / CTAGT). [0069]  [0069] [0070] 如上所指出的，本发明的内部对照物包括至少两个引物结合位点和至少一个探针结合位点。  [0070] As indicated above, the internal controls of the present invention comprises at least two primer binding sites and at least one probe binding site. 表10到12阐述了各种正向和反向扩增引物序列和检测探针结合序列，其可被用于产生玉米IC扩增子，这也在表格中提供了。  Table 10 and 12 set forth various forward and reverse amplification primer sequences and detection probe binding sequences that can be used to generate an amplicon maize IC, which is also provided in the table. 表10到12中阐述的扩增子可以用于制备用于以下疾病状态的核酸诊断测试的非竞争性对照物：甲型流感、乙型流感、副流感病毒1 到4(PIV-1到PIV-4)、A型呼吸道合胞体病毒（RSVA)、RSV B、人类偏肺病毒（hMPV)、沙眼衣原体（CT)、NeiSSeriag0n0rrhea(GC)、乙型肝炎病毒（HBV)、丙型肝炎病毒（HCV)、人类免疫缺陷病毒I (HIV-1)和严重急性呼吸综合征（SARS)。  Table 10 set forth in the amplicon 12 may be used to control noncompetitive nucleic acid diagnostic tests for the preparation of the following disease states: Influenza A, Influenza B, parainfluenza virus 1 to 4 (PIV-1 to PIV -4), A-type respiratory syncytial virus (RSVA), RSV B, human metapneumovirus (hMPV), Chlamydia trachomatis (CT), NeiSSeriag0n0rrhea (GC), hepatitis B virus (HBV), hepatitis C virus (HCV ), human immunodeficiency virus I (HIV-1) and severe acute respiratory syndrome (SARS). [0071]  [0071] [0072]  [0072] [0073]  [0073] [0074] 要理解的是，虽然连同其优选的具体实施方式描述了本发明，以上的描述以及随后的实施例意图说明而不是限制本发明的范围。  [0074] is to be understood that while the preferred embodiment with its described embodiments of the present invention, the above description and the subsequent examples are intended to illustrate and not limit the scope of the present invention. 本发明的范围内的其他方面、优点和修改对于本发明所属领域技术人员是显而易见的。  Other aspects, advantages and modifications within the scope of the invention to those skilled in the present invention will be apparent. [0075] 在此提及的所有专利和公开文件通过引用完全合并在此。  [0075] All patents and publications mentioned herein are fully incorporated by reference herein. 实施例  Example [0076] 提出以下实施例，以为本领域普通技术人员提供如何制造和使用本发明的组合物的完整公开和描述。  [0076] The following examples, that those of ordinary skill in the art to provide a complete disclosure and description of how to make and use the compositions of the present invention. 实施例意图作为本发明的非限制性实例。  The examples are intended as non-limiting examples of the invention. 虽然已经进行了努力来确保关于变量，例如，数量、温度等等的准确度，实验误差和偏离应当被考虑。  Although efforts have been made to ensure on variables such as quantity, temperature, etc. accuracy, experimental error and deviation should be considered. 除非另外标明，份数是按重量份，温度是摄氏度，压力是处在或接近大气压。  Unless otherwise indicated, parts are parts by weight, temperature is in degrees Centigrade, and pressure is at or near atmospheric. 除非另有陈述，所有的成分是商业上获得的。  Unless otherwise stated, all the ingredients are available commercially. [0077] —般方案：  [0077] - like program: [0078] 以下方案、装置和试剂盒被用于进行以下实施例。  [0078] The following schemes, apparatus, and kits are used in the following examples. [0079] 基因组DNA的提取：通过人工的Qiagen (Valencia, CA)样品制备试剂盒纯化的天然目标。  [0079] Genomic DNA Extraction: artificial purified by the Qiagen (Valencia, CA) sample preparation kit natural target. [0080] PCR条件和装置：PCR在MJ Research (Ramsey，MN)仪器上使用以下热分布来进行： 95° 10分钟-1步  [0080] PCR conditions and apparatus: PCR is performed using the following thermal profile on MJ Research (Ramsey, MN) Instrument: 95 ° 10 minutes to 1 step [0081]  [0081] [0082] 72° 10 分钟  [0082] 72 ° 10 minutes [0083] 4°过夜（直到移除）  [0083] 4 ° overnight (until removed) [0084] PCR产物的纯化：PCR产物利用Qiagen试剂盒（Valencia，CA)来纯化。  Purification [0084] PCR products: PCR product was purified using the Qiagen kit (Valencia, CA). [0085] 克隆操作：克隆利用用于在使用TOPO®克隆  [0085] cloning operations: TOPO® cloning using cloning using ^ZW (Carlsbad, CA) StJ Invitrogen克隆方案的产品插页中阐述的操作来进行。  ^ ZW (Carlsbad, CA) cloning product inserts StJ Invitrogen scheme set forth for operation. 连接操作：DNA片段向TOPO®克隆载体的连接利用Invitrogen T4连接酶（Carlsbad，CA)的说明来进行。  Connection operations: DNA fragments were ligated to a cloning vector using the TOPO® described Invitrogen T4 ligase (Carlsbad, CA) to perform. [0086] 载体片段的纯化：载体的纯化利用ClontechNUCLEOSPIN® RNA纯化试剂盒(Mountain View, CA)来进行。  Purification [0086] vector fragment: vector ClontechNUCLEOSPIN® RNA purification is performed using purification kit (Mountain View, CA). [0087] RNA 转录方案：转录根据Ambion T7 MEGASCRIPT®试剂盒（Austin，TX)的产品插页中的说明来进行。  [0087] RNA transcribed scheme: transcription according Ambion T7 MEGASCRIPT® kit (Austin, TX) as described in the product insert. RNA的纯化根据QiagenRNEASY®迷你试剂盒（Valencia， CA)中的说明来进行。  RNA was purified according to QiagenRNEASY® Mini Kit (Valencia, CA) as described. [0088] 实施例1  [0088] Example 1 [0089] MET IC DNA插入物序列的制备  Preparation of [0089] MET IC DNA insert sequence of [0090] 基因组DNA从MET样品提取。  [0090] Genomic DNA was extracted from the sample MET. DNA插入物通过使用表1的片段引物对基因组DNA 进行PCR来制备。  DNA insert fragment of primer 1 genomic DNA was prepared by PCR was carried out using a table. 以下序列是MET IC PCR产物(213bp)的序列(SEQ ID NO :37)。  The following sequence is MET IC PCR product (213 bp) sequence (SEQ ID NO: 37). Xhol和Spel限制性酶位点用黑体下划线标出。  Xhol and Spel restriction enzyme sites are indicated in bold underlined. [0091]  [0091] [0092]  [0092] AGTAGTC TCG  AGTAGTC TCG AG CATGTGCA  AG CATGTGCA TCATCAG AGC  TCATCAG AGC TC GTACACGT  TC GTACACGT GGGATCCTGA CCCTAGGACT  GGGATCCTGA CCCTAGGACT CACGGTACTG GTGCCATGAC  CACGGTACTG GTGCCATGAC [0093] 41 GAGGCAGGCA GGGCCGCCAT AAGAGCCATA GAGGAGGTTG[0094] CTCCGTCCGT CCCGGCGGTA TTCTCGGTAT CTCCTCCAAC[0095] 81 AGGGTGTTGT GACGCCCTTT GATATCTGCT CCGCAGCATC[0096] TCCCACAACA CTGCGGGAAA CTATAGACGA GGCGTCGTAG[0097] 121 AAAGCCAGAG ACAAATTACC CCTGGATAGG CCCCACCACG[0098] TTTCGGTCTC TGTTTAATGG GGACCTATCC GGGGTGGTGC[0099] 161 AACCACCCCT ACTGCCCGAG CCTGAAGGAG GTGCTCGGTG[0100] TTGGTGGGGA TGACGGGCTC GGACTTCCTC CACGAGCCAC[0101] 201 AA CTAGT CGA CGA [0102] TT GATCA GCT GCT  [0093] 41 GAGGCAGGCA GGGCCGCCAT AAGAGCCATA GAGGAGGTTG [0094] CTCCGTCCGT CCCGGCGGTA TTCTCGGTAT CTCCTCCAAC [0095] 81 AGGGTGTTGT GACGCCCTTT GATATCTGCT CCGCAGCATC [0096] TCCCACAACA CTGCGGGAAA CTATAGACGA GGCGTCGTAG [0097] 121 AAAGCCAGAG ACAAATTACC CCTGGATAGG CCCCACCACG [0098] TTTCGGTCTC TGTTTAATGG GGACCTATCC GGGGTGGTGC [0099] 161 AACCACCCCT ACTGCCCGAG CCTGAAGGAG GTGCTCGGTG [0100] TTGGTGGGGA TGACGGGCTC GGACTTCCTC CACGAGCCAC [0101] 201 AA CTAGT CGA CGA [0102] TT GATCA GCT GCT [0103] 实施例2  [0103] Example 2 [0104] 纯化的MET IC DNA插入物序列  [0104] Purified MET IC DNA insert sequence [0105] 以下序列是在上文鉴定的位点处限制性内切酶消化后纯化的195bp dsDNA序列  [0105] The following sequence is cut after purification digested at the restriction enzyme site at 195bp dsDNA sequences identified above (SEQ ID NO ： 38)： [0106] 1 TCGAGCATGT GCAGGGATCC TGACACGGTA CTGGAGGCAG[0107] 41 GCAGGGCCGC CATAAGAGCC ATAGAGGAGG TTGAGGGTGT[0108] 81 TGTGACGCCC TTTGATATCT GCTCCGCAGC ATCAAAGCCA[0109] 121 GAGACAAATT ACCCCTGGAT AGGCCCCACC ACGAACCACC[0110] 161 CCTACTGCCC GAGCCTGAAG GAGGTGCTCG GTGAA[0111] 实施例3  (SEQ ID NO: 38): [0106] 1 TCGAGCATGT GCAGGGATCC TGACACGGTA CTGGAGGCAG [0107] 41 GCAGGGCCGC CATAAGAGCC ATAGAGGAGG TTGAGGGTGT [0108] 81 TGTGACGCCC TTTGATATCT GCTCCGCAGC ATCAAAGCCA [0109] 121 GAGACAAATT ACCCCTGGAT AGGCCCCACC ACGAACCACC [0110] 161 CCTACTGCCC GAGCCTGAAG GAGGTGCTCG GTGAA [0111 ] Example 3 [0112] MET IC DNA转录产物序列  [0112] MET IC DNA transcript sequence [0113] 通过将实施例2的纯化的MET IC DNA插入物序列连接到纯化的载体片段并添加T7启动子序列，来制备质粒。  [0113] Example 2 is purified by the MET IC DNA insert sequence the embodiment is connected to a purified vector fragment and T7 promoter sequence is added to prepare a plasmid. 纯化的载体片段经由限制性内切酶Xhol和Spel的消化分离自TOPO®克隆载体（Invitrogen，Carlsbad, California)。  The purified vector fragment was isolated by digestion enzymes Xhol and Spel restriction via the self-TOPO® cloning vector (Invitrogen, Carlsbad, California). 通过匹配DNA插入物和载体的Xhol和Spel粘性末端形成质粒。  Formed by matching the DNA insert of plasmid vector Xhol and Spel and sticky ends. 附图1显示了克隆过程的示意图。  Figure 1 shows a schematic of the cloning process. 16[0114] 产生的质粒用Xhol和Spel线性化，来产生以下的247bp MET ICDNA转录产物序列。  16 [0114] The resulting plasmid was linearized with Xhol and Spel to generate the following sequence of 247bp MET ICDNA transcript. 载体序列是用粗体下划线突出的(SEQ ID NO ：39)：  Vector sequences are bold underlined projecting (SEQ ID NO: 39): 0115] 1 GGGCGAATTG GGCCCTCTAG ATGCATG CTC 「KATm 0116] 41 AGGGATCCTG ACACGGTACT GGAGGCAGGC AGGGCCGCCA0117] 81 TAAGAGCCAT AGAGGAGGTT GAGGGTGTTG TGACGCCCTT0118] 121 TGATATCTGC TCCGCAGCAT CAAAGCCAGA GACAAATTAC0119] 161 CCCTGGATAG GCCCCACCAC GAACCACCCC TACTGCCCGA0120] 201 GCCTGAAGGA GGTGCTCGGT GAACTAGT GG ATCCGAGCTC0121] 241 GGTACCA 0122] 实施例4 0123] MET IC RNA转录产物序列 0124] 以下序列是从实施例3的DNA序列制备的247bp MET IC RNA转录产物序列。  0115] 1 GGGCGAATTG GGCCCTCTAG ATGCATG CTC  " KATm 0116] 41 AGGGATCCTG ACACGGTACT GGAGGCAGGC AGGGCCGCCA0117] 81 TAAGAGCCAT AGAGGAGGTT GAGGGTGTTG TGACGCCCTT0118] 121 TGATATCTGC TCCGCAGCAT CAAAGCCAGA GACAAATTAC0119] 161 CCCTGGATAG GCCCCACCAC GAACCACCCC TACTGCCCGA0120] 201 GCCTGAAGGA GGTGCTCGGT GAACTAGT GG ATCCGAGCTC0121] 241 GGTACCA 0122] Example 40 123 ] MET IC RNA transcript sequence 0124] the following sequence is 247bp MET IC RNA transcript sequence prepared from the DNA sequence of the third embodiment. 体序列是用粗体下划线突出的(SEQ ID NO ：40)：  Bold underlined sequences are projecting (SEQ ID NO: 40): 0125] 1 GGGCGAAUUG GGCCCUCUAG AUGCAUG air GAGCAIIGIIGr 0126] 41 AGGGAUCCUG ACACGGUACU GGAGGCAGGC AGGGCCGCCA0127] 81 UAAGAGCCAU AGAGGAG⑶U GAGGGUGUUG UGACGCCCUU0128] 121 UGAUAUCUGC UCCGCAGCAU CAAAGCCAGA GACAAAUUAC0129] 161 CCCUGGAUAG GCCCCACCAC GAACCACCCC UACUGCCCGA0130] 201 GCCUGAAGGA G⑶GCUCGGU GAACUAGU GG AUCCGAGCUC0131] 241 GGUACCA 0132] 实施例5 0133] 玉米IC插入物序列的制备 0134] 基因组DNA从玉蜀黍（玉米）样品提取。  0125] 1 GGGCGAAUUG GGCCCUCUAG AUGCAUG air GAGCAIIGIIGr 0126] 41 AGGGAUCCUG ACACGGUACU GGAGGCAGGC AGGGCCGCCA0127] 81 UAAGAGCCAU AGAGGAG⑶U GAGGGUGUUG UGACGCCCUU0128] 121 UGAUAUCUGC UCCGCAGCAU CAAAGCCAGA GACAAAUUAC0129] 161 CCCUGGAUAG GCCCCACCAC GAACCACCCC UACUGCCCGA0130] 201 GCCUGAAGGA G⑶GCUCGGU GAACUAGU GG AUCCGAGCUC0131] 241 GGUACCA 0132] Example 50 133] preparation insert sequence of maize IC 0134] genomic DNA was extracted from maize (corn) sample. DNA插入物通过使用表9的片段引物对基  Insert DNA fragment was purified by using the primers in Table 9 of the base 因组DNA进行PCR来制备。  Genomic DNA was prepared for PCR. 以下序列是玉米ICPCR产物（284bp)的序列（SEQ ID NO :41)。  The following sequence is maize ICPCR product (284 bp) sequence (SEQ ID NO: 41). Xhol和Spel限制性内切酶位点是用粗体下划线标明的。  The Xhol and Spel restriction enzyme site is underlined in bold. 0135] 1 AGTAGTC TCG AG TAAATAGC CCTCACCCAC CAACTAGCCG0136] TCATCAG AGC TC ATTTATCG GGAGTGGGTG GTTGATCGGC0137] 41 TTACAGGCAA GTTACTGCGC GATGGCGCAC CGGACAGTCC0138] AATGTCCGTT CAATGACGCG CTACCGCGTG GCCTGTCAGG0139] 81 GGTGCGCCAC CGGTGCGCCA CCGGTGCGCC ACCGGTGCGC0140] CCACGCGGTC GCCACGCGGT GGCCACGCGG TGGCCACGCG0141] 121 CAACGGTCAC TTNCAACGGC TAGTTCTGAC ACAGAGCCGT0142] GTTGCCAGTG AANGTTGCCG ATCAAGACTG TGTCTCGGCA 0143] 161 TGGACTCATG ACGCACCGGA CAGTGAATAG TTCACTGTCC0144] ACCTGAGTAC TGCGTGGCCT GTCACTTATC AAGTGACAGG0145] 201 GGTGCACACC GGACAGTCCG GTGCGGTGTC CGGTGTGCCA0146] CCACGTGTGG CCTGTCAGGC CACGCCACAG GCCACACGGT0147] 241 CTAAAATTCA TCTCCGAAGC CTGCGCTCTC GGA CTAGT CG0148] GATTTTAAGT AGAGGCTTCG GACGCGAGAG CCT GATCA GC0149] 281 ACGA  0135] 1 AGTAGTC TCG AG TAAATAGC CCTCACCCAC CAACTAGCCG0136] TCATCAG AGC TC ATTTATCG GGAGTGGGTG GTTGATCGGC0137] 41 TTACAGGCAA GTTACTGCGC GATGGCGCAC CGGACAGTCC0138] AATGTCCGTT CAATGACGCG CTACCGCGTG GCCTGTCAGG0139] 81 GGTGCGCCAC CGGTGCGCCA CCGGTGCGCC ACCGGTGCGC0140] CCACGCGGTC GCCACGCGGT GGCCACGCGG TGGCCACGCG0141] 121 CAACGGTCAC TTNCAACGGC TAGTTCTGAC ACAGAGCCGT0142] GTTGCCAGTG AANGTTGCCG ATCAAGACTG TGTCTCGGCA 0143 ] 161 TGGACTCATG ACGCACCGGA CAGTGAATAG TTCACTGTCC0144] ACCTGAGTAC TGCGTGGCCT GTCACTTATC AAGTGACAGG0145] 201 GGTGCACACC GGACAGTCCG GTGCGGTGTC CGGTGTGCCA0146] CCACGTGTGG CCTGTCAGGC CACGCCACAG GCCACACGGT0147] 241 CTAAAATTCA TCTCCGAAGC CTGCGCTCTC GGA CTAGT CG0148] GATTTTAAGT AGAGGCTTCG GACGCGAGAG CCT GATCA GC0149] 281 ACGA 0150] TGCT  0150] TGCT 0151] 实施例6  0151] Example 6 0152] 纯化的玉米IC DNA插入物序列  0152] Purified corn IC DNA insert sequence 0153] 以下序列是在上文鉴定的位点处限制性内切酶消化后纯化的266bp dsDNA序列  After purification 0153] The following sequence is a restriction endonuclease digestion at sites in the above-identified sequence of 266bp dsDNA SEQ ID NO ： 42)： 0154] 1 TCGAGTAAAT AGCCCTCACC CACCAACTAG CCGTTACAGG0155] 41 CAAGTTACTG CGVGATGGCG CACCGGACAG TCCGGTGCGC0156] 81 CACCGGTGCG CCACCGGTGC GCCACCGGTG CGCCAACGGT0157] 121 CACTTCCAAC GGCTAGTTCT GACACAGAGC CGTTGGACTC0158] 161 ATGACGCACC GGACAGTGAA TAGTTCACTG TCCGGTGCAC0159] 201 ACCGGACAGT CCGGTGCGGT GTCCGGTGTG CCACTAAAAT0160] 241 TCATCTCCGA AGCCTGCGCT CTCGGA 0161] 实施例7  SEQ ID NO: 42): 0154] 1 TCGAGTAAAT AGCCCTCACC CACCAACTAG CCGTTACAGG0155] 41 CAAGTTACTG CGVGATGGCG CACCGGACAG TCCGGTGCGC0156] 81 CACCGGTGCG CCACCGGTGC GCCACCGGTG CGCCAACGGT0157] 121 CACTTCCAAC GGCTAGTTCT GACACAGAGC CGTTGGACTC0158] 161 ATGACGCACC GGACAGTGAA TAGTTCACTG TCCGGTGCAC0159] 201 ACCGGACAGT CCGGTGCGGT GTCCGGTGTG CCACTAAAAT0160] 241 TCATCTCCGA AGCCTGCGCT CTCGGA 0161 ] Example 7 0162] 0163]  0162] 0163] 玉米IC DNA转录产物序列  Corn IC DNA transcript sequence 通过将实施例6的纯化的MET玉米IC DNA插入物序列连接到具有粘性末端限制生位点和T7启动子序列的纯化的载体片段，来制备质粒。  Example 6 will be purified by a MET embodiment corn IC DNA insert sequence having cohesive ends connected to the raw restriction site and purified vector fragment of the T7 promoter sequence, the plasmid was prepared. 纯化的载体片段经由限制性内切酶Xhol 和Spel 的消化分离自TOPO® 克隆载体(Invitrogen, Carlsbad, California)。  The purified vector fragment was isolated by digestion enzymes Xhol and Spel restriction via the self-TOPO® cloning vector (Invitrogen, Carlsbad, California). 通过匹配DNA插入物和载体的Xhol和Spel粘性末端形成质粒。  Formed by matching the DNA insert of plasmid vector Xhol and Spel and sticky ends. 附图1显示了克隆过程的示意图。  Figure 1 shows a schematic of the cloning process. [0164] 产生的质粒用Xhol和Spel线性化，来产生以下的318bp玉米I⑶NA转录产物序列。  [0164] The resulting plasmid was linearized with Xhol and Spel to generate the following maize I⑶NA 318bp transcript sequences. 载体序列用粗体下划线突出(SEQ ID NO ：43)：  Vector sequences in bold underlined projection (SEQ ID NO: 43): [0165] 1 GGGCGAATTG GGCCCTCTAG ATGCATG CTC GAGTAAATAG [0166] 41 CCCTCACCCA CCAACTAGCC GTTACAGGCA AGTTACTGCG[0167] 81 CGATGGCGCA CCGGACAGTC CGGTGCGCCA CCGGTGCGCC[0168] 121 ACCGGTGCGC CACCGGTGCG CCAACGGTCA CTTNCAACGG[0169] 161 CTAGTTCTGA CACAGAGCCG TTGGACTCAT GACGCACCGG[0170] 201 ACAGTGAATA GTTCACTGTC CGGTGCACAC CGGACAGTCC[0171] 241 GGTGCGGTGT CCGGTGTGCC ACTAAAATTC ATCTCCGAAG[0172] 281 CCTGCGCTCT CGGACTAGT G CATCCGAGCT CGGTACCA [0173] 实施例8 [0174] 玉米IC RNA转录产物序列 [0175] 以下序列是从实施例7的DNA序列制备的318bp玉米IC RNA转录产物序列。  [0165] 1 GGGCGAATTG GGCCCTCTAG ATGCATG CTC GAGTAAATAG [0166] 41 CCCTCACCCA CCAACTAGCC GTTACAGGCA AGTTACTGCG [0167] 81 CGATGGCGCA CCGGACAGTC CGGTGCGCCA CCGGTGCGCC [0168] 121 ACCGGTGCGC CACCGGTGCG CCAACGGTCA CTTNCAACGG [0169] 161 CTAGTTCTGA CACAGAGCCG TTGGACTCAT GACGCACCGG [0170] 201 ACAGTGAATA GTTCACTGTC CGGTGCACAC CGGACAGTCC [ 8 [0174] corn IC RNA transcript sequence [0175] the following sequence 0171] 241 GGTGCGGTGT CCGGTGTGCC ACTAAAATTC ATCTCCGAAG [0172] 281 CCTGCGCTCT CGGACTAGT G CATCCGAGCT CGGTACCA [0173] Example is 318bp maize IC RNA prepared from a DNA sequence of Example 7 transcript sequences. 体序列用粗体下划线突出(SEQ ID NO ：44)  Bold underlined sequences projection (SEQ ID NO: 44) [0176] 1 GGGCGAAUUG GGCCCUCUAG AUGCAUG QIC GArTlIAAAIIArT [0177] 41 CCCUCACCCA CCAACUAGCC GUUACAGGCA A⑶UACUGCG[0178] 81 CGAUGGCGCA CCGGACA⑶C CG⑶GCGCCA CCG⑶GCGCC[0179] 121 ACCGGUGCGC CACCG⑶GCG CCAACGGUCA CUUNCAACGG[0180] 161 CUAGUUCUGA CACAGAGCCG UUGGACUCAU GACGCACCGG  [0176] 1 GGGCGAAUUG GGCCCUCUAG AUGCAUG QIC GArTlIAAAIIArT [0177] 41 CCCUCACCCA CCAACUAGCC GUUACAGGCA A⑶UACUGCG [0178] 81 CGAUGGCGCA CCGGACA⑶C CG⑶GCGCCA CCG⑶GCGCC [0179] 121 ACCGGUGCGC CACCG⑶GCG CCAACGGUCA CUUNCAACGG [0180] 161 CUAGUUCUGA CACAGAGCCG UUGGACUCAU GACGCACCGG 18[0181] 201 ACA⑶GAAUA GUUCACU⑶C CGGUGCACAC CGGACAGUCC  18 [0181] 201 ACA⑶GAAUA GUUCACU⑶C CGGUGCACAC CGGACAGUCC [0182] 241 G ⑶ GCGGUGU CCG ⑶⑶ GCC ACUAAAAUUC AUCUCCGAAG  [0182] 241 G ⑶ GCGGUGU CCG ⑶⑶ GCC ACUAAAAUUC AUCUCCGAAG [0183] 281 CCUGCGCUCU CGGACUAGU §-CAOCCGAGCU-CGGPACCA  [0183] 281 CCUGCGCUCU CGGACUAGU §-CAOCCGAGCU-CGGPACCA [0184] 实施例9  [0184] Example 9 [0185]在 CT、GC 和HCV 分析中MET IC 的用途用TAQMAN® 探针（Applied Biosystems, Foster City，CA)对CT、GC和HCV分别进行独立的RT-PCR分析。  [0185] MET IC applications in CT, GC analysis of HCV and CT, GC and HCV independent RT-PCR analysis with TAQMAN® probe (Applied Biosystems, Foster City, CA), respectively. 每个分析包括处在单独的反应孔中的目标核酸（CT和GC的DNA，HCV的RNA)以及本发明的MET IC。  Each analysis includes the target nucleic acid in a separate reaction wells (CT and GC of DNA, HCV of RNA) and MET IC according to the present invention. 附图2、3和4显示了扩增分析的结果（循环数对比deltaRn)。  Figures 2, 3 and 4 show the results (number of cycles Comparative DeltaRn) amplification analysis. Rn，标准化的报告物信号，是报告物染料的荧光信号除以内部参考染料的荧光信号。  Rn, normalized reporter signal, the signal is a fluorescent reporter dye divided by the internal reference dye fluorescence signal. Delta Rn(dRn)通过公式Rn+_Rn_来确定，其中旧+是涉及所有成分的反应的Rn值，Rn_是未反应的样品的值。  Delta Rn (dRn) by the formula Rn + _Rn_ determined, where the old + is the Rn value relates to the reaction of all the components, the value RN_ unreacted sample. 在每个图中，左侧的曲线代表目标的扩增，右侧的曲线代表IC的扩增。  In each figure, the left side of the curve representing the amplification of the target, the amplification curve representing the right side of the IC. 19  19 